No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 5 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) stock was $2.20 as of Oct 6, 2026, 9:53 AM EDT, down 2.44% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -74.7%
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds.
Medical - Instruments & Supplies · Singapore, CE
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
$26790.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1CUPR | $5.89M | $2.19 | -2.44% | -74.72% | N/A | N/A | N/A |
| 2LUCY | $5.92M | $0.94 | +5.61% | -55.10% | N/A | N/A | vs CUPR |
| 3CDIO | $6.04M | $2.04 | -0.97% | -54.55% | N/A | N/A | vs CUPR |
| 4ENLV | $6.06M | $0.36 | -0.52% | -97.68% | -69.81% | -54.76% | vs CUPR |
| 5ACXP | $5.63M | $1.31 | -0.05% | -71.04% | -57.41% | N/A | vs CUPR |
| 6INBS | $5.57M | $1.68 | +0.60% | -85.59% | -80.26% | N/A | vs CUPR |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$2.19
High
N/A
